causal

Clinical Benefit Magnitude Is Hardest to Predict

The dimension investors most often get wrong is the magnitude of clinical benefit, because clinical benefit is not black and white and a drug must be meaningfully differentiated from existing or slightly-worse competitors to succeed in a competitive market.

causalpending

Speaker

Tal Zaks

Evidence Quote

“the one that we get probably the most wrong is the one that is still the hardest to predict, which is what is the magnitude of clinical benefit that this will bring?”

Source

Bridging Science, Medicine, and Returns— Invest Like the Best
Created: 11/19/2026, 4:01:33 PM

Your notes

Loading notes...